PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry

Publisher Name :
Date: 30-Apr-2013
No. of pages: 80
Inquire Before Buying

PharmaSphere: Early-Stage Technology Transfer Collaborations Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry"" report provides a cross-section of major licensing deals between mid to large-sized pharmaceutical companies and academic and nonprofit research institutions. This report examines the terms, platform technologies, and deal rationale of 25 pharma-academic alliances from 2012–2013. GlobalData’s Industry Dynamics team of analysts discusses the significant macro-environment drivers which are leading to an increase in research partnerships with academic research institutions on behalf of pharmaceutical companies. We also discuss the unsustainability of the current drug research model, and the industry’s attempts at moving toward an open R&D ecosystem.

Highlights

Key Questions Answered


  • What are the reasons for increased activity in strategic deals with academia by leading pharmaceutical companies and promising biotechs?

  • What are the deal terms of these collaboration agreements?

  • What therapeutic areas and geographic markets are pharmaceutical companies targeting to partner with academic research institutions?

  • What proprietary platforms and enabling technologies are these pharmaceutical companies trying to access?


Key Findings

  • With the patent cliff and high R&D costs eroding corporate profitability, pharmaceutical companies will look for ways to replenish their pipelines by reaching out to academia in search of novel drug platforms

  • Despite the FDA approving 39 new drugs in 2012, the innovation gap continues, as many of these medicines are ‘me-too’ drugs, or orphan drugs indicated to treat small segments of the population suffering from rare diseases

  • Difficulty accessing capital and the continued economic recession have led to a deal adverse environment resulting in deals to decline on a global basis

  • Oncology, CNS, immunology and infectious diseases still remain hot therapeutic areas to strike licensing deals with academia


Scope

  • Full examination of 25 significant technology transfer deals from 2012 and 2013 involving large pharmaceutical companies and academic organizations including licensing structure and terms

  • Analysis of the key drivers, trends, and strategies behind the deals undertaken by these pharmaceutical companies across major therapeutic areas

  • Discussion of the unsustainability of the current drug research model and how Big Pharma’s embrace of collaboration and an open ecosystem could drive the next wave of scientific discovery

  • Tech Transfer in Action : Each section of the report includes a number of case studies and to highlight major themes within technology transfer

  • Platform assessment on enabling drug technologies being employed by academic research institutions of interest to pharmaceutical companies

  • Breakdown of disruptive innovation trends, including open-source patient data, pre-competitive information sharing, ‘Big Data’ and drug recycling/repurposing approaches


Key Benefits

  • Analyze and track the strategies that these pharmaceutical companies are using to gain share in an increasingly competitive marketplace

  • Target academic institutions with novel and proprietary technologies to maximize opportunities for strategic investment or partnerships

  • Formulate effective licensing strategies by understanding the various factors and deal terms considered when structuring tech-transfer partnerships

  • Use information as an independent source for your due diligence and transaction strategies

PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry

Table Of Contents

1 Table of Contents 4
1.1 List of Tables 9
1.2 List of Figures 10

2 Introduction 11
2.1 Catalyst 11
2.2 Related Reports 12
2.3 About PharmaSphere Report Series 13

3 A Changing and Challenging Deal Making Landscape 14
3.1 Overview 14
3.2 Deal Drivers 15
3.2.1 The Patent Cliff 15
3.2.2 Deal-Adverse Environment 18
3.2.3 Spike in Regulatory Approvals but Innovation Gap Continues 22
3.2.4 FDA’s Proposal to Lower Regulatory Standards in Early-Stage Alzheimer’s Research 23
3.2.5 More Stringent Regulatory Regime in a Post-Vioxx and Avandia World 24
3.2.6 Viewpoint: Vioxx and Avandia Cases 25

4 An Unsustainable R&D Paradigm 27
4.1 Big Pharma’s Embrace of Disruptive Innovation May Fix Broken R&D Model 28
4.1.1 Pre-Competitive Information Sharing 28
4.1.2 Open-Source Patient Data 29
4.1.3 ‘Big Data’ and Drug Discovery 30
4.1.4 Tech Transfer in Action: Astellas Pharma Taps IT for Drug Discovery 31
4.1.5 Drug Recycling 31
4.1.6 Viewpoint: Drug Repurposing at NCATS 32
4.1.7 Tech Transfer in Action: Roche & Broad Join to Bring Failed Drugs Back from the Dead 33

5 Major Global Technology Transfer Alliances 34
5.1 The Bayh-Dole Act of 1980 34
5.2 Deals Overview 36
5.3 Biscayne Pharma Enters into Licensing Agreement with University of Miami for Growth Hormone-Releasing Technology 40
5.3.1 Deal Summary 40
5.3.2 Deal Analysis 40
5.4 Genoa Pharma Enters into Research Agreement with McMaster University for IPF 42
5.4.1 Deal Summary 42
5.4.2 Deal Analysis 42
5.5 AstraZeneca Partners with Vanderbilt University for Neuroscience Drug Discovery 44
5.5.1 Deal Summary 44
5.5.2 Deal Analysis 44
5.6 Trovagene Grants License for NPM1 Marker for AML to Duke University 45
5.6.1 Deal Summary 45
5.6.2 Deal Analysis 45
5.7 Synthetic Biologics and University of Texas Ink Research Deal to Fight Pertussis 47
5.7.1 Deal Summary 47
5.7.2 Deal Analysis 47
5.8 BMS and Vanderbilt University Sign Deal to Develop Drugs for Parkinson’s 49
5.8.1 Deal Summary 49
5.8.2 Deal Analysis 49
5.9 AstraZeneca and Broad Institute Partner to Advance Discovery of Antibacterial and Antiviral Agents 50
5.9.1 Deal Summary 50
5.9.2 Deal Analysis 50
5.10 Bayer HealthCare Opens New Lab Space – The CoLaborator – for Biotech Startups 51
5.10.1 Deal Summary 51
5.10.2 Deal Analysis 51
5.11 Novartis Enters into Licensing Agreement with Penn for CART-19 53
5.11.1 Deal Summary 53
5.11.2 Deal Analysis 53
5.12 Sanofi and BWH Agree to Develop Antibodies for Type 1 Diabetes 55
5.12.1 Deal Summary 55
5.12.2 Deal Analysis 55
5.13 AstraZeneca and Leading Academic Organizations Collaborate on Alzheimer’s Research 56
5.13.1 Deal Summary 56
5.13.2 Deal Analysis 56
5.14 Novo Nordisk Enters into R&D Agreement with JDRF for Type 1 Diabetes 57
5.14.1 Deal Summary 57
5.14.2 Deal Analysis 57
5.15 Large Pharmas Unite with the Genome Institute of Singapore to Combat Cancer in Asian Populations 58
5.15.1 Deal Summary 58
5.15.2 Deal Analysis 58
5.15.3 Tech Transfer in Action: National University Singapore Startup AyoxxA Biosystems 59
5.16 University of Washington and ‘Big Pharma’ Join Forces to Research Drug Transporters 60
5.16.1 Deal Summary 60
5.16.2 Deal Analysis 60
5.17 Pharma and the University of Dundee Create Consortium on Cell Signaling Research 61
5.17.1 Deal Summary 61
5.17.2 Deal Analysis 61
5.18 Novo Nordisk and Oxford Join to Identify Novel Biomarkers for Rheumatoid Arthritis 62
5.18.1 Deal Summary 62
5.18.2 Deal Analysis 62
5.19 Elan Corporation and University of Cambridge Enter into Joint Venture to Discover New Therapies Targeting Neurodegenerative Disorders 63
5.19.1 Deal Summary 63
5.19.2 Deal Analysis 63
5.20 GSK and Yale Partner to Develop New Drugs Targeting Disease-Causing Proteins 64
5.20.1 Deal Summary 64
5.20.2 Deal Analysis 64
5.21 Big Pharma Companies and Research Institutions Tackle Early-Stage Research TB 65
5.21.1 Deal Summary 65
5.21.2 Deal Analysis 65
5.22 Accuray Signs Collaboration Agreement with University of Heidelberg to Provide Cutting-edge Research in Radiation Oncology 66
5.22.1 Deal Summary 66
5.22.2 Deal Analysis 66
5.23 UCB and Oxford University Join to Focus on Developing Innovative Medicines for Immunological and Neurological Disorders 67
5.23.1 Deal Summary 67
5.23.2 Deal Analysis 67
5.24 Large Pharma and King’s College London Establish a Center to Tackle Autism 69
5.24.1 Deal Summary 69
5.24.2 Deal Analysis 69
5.25 Merck Establishes an Independent Non-profit Drug Research Institute – the California Institute for Biomedical Research 70
5.25.1 Deal Summary 70
5.25.2 Deal Analysis 70
5.26 J&J and University of Queensland Develop Drugs Using Spider Venom for Treating Pain 71
5.26.1 Deal Summary 71
5.26.2 Deal Analysis 71
5.27 Sanofi and UCSF Form a Pact to Work on New Treatments for Diabetes 73
5.27.1 Deal Summary 73
5.27.2 Deal Analysis 73
5.27.3 Tech Transfer in Action: Tufts University Spin-off Anchor Therapeutics 74

6 Future Outlook 76

7 Appendix 77
7.1 Research Methodology 77
7.1.1 Coverage 77
7.1.2 Secondary Research 77
7.1.3 Expert Panel Validation 78
7.2 About the Author 78
7.2.1 Analyst 78
7.3 Director, Healthcare Industry Dynamics 79
7.4 Global Head of Healthcare 79
7.5 About the Industry Dynamics Team 79
7.6 GlobalData 80
7.7 Contact Us 80
7.8 Disclosure Information 80
7.9 Disclaimer 80

List Of Tables

Table 1: Recent and Upcoming US Patent Expirations with FY2011 and FY2012 Sales Data 16
Table 2: Deals Summary of Major Technology Transfer Alliances, January 2012–January 2013 38
Table 3: Biscayne Pharma & University of Miami, Deal Summary, 2013 40
Table 4: Genoa Pharma & McMaster University, Deal Summary, 2013 42
Table 5: AstraZeneca & Vanderbilt University, Deal Summary, 2013 44
Table 6: Trovagene & Duke University, Deal Summary, 2012 45
Table 7: Synthetic Biologics & University of Texas, Deal Summary, 2012 47
Table 8: BMS & Vanderbilt University, Deal Summary, 2012 49
Table 9: AstraZeneca & Broad Institute, Deal Summary, 2012 50
Table 10: Bayer HealthCare & Aronora, ProLynx, Deals Summary 2012 51
Table 11: Novartis & University of Pennsylvania, Deal Summary 2012 53
Table 12: Sanofi & Brigham and Women’s Hospital, Deal Summary 2012 55
Table 13: AstraZeneca & Leading Academic Organizations, Deal Summary 2012 56
Table 14: Novo Nordisk & JDRF, Deal Summary 2012 57
Table 15: Eli Lilly, Merck, Pfizer & Genome Institute of Singapore, Deal Summary 2012 58
Table 16: AZ, Genentech, Merck & University of Washington in St. Louis, Deal Summary 2012 60
Table 17: Pharma & University of Dundee, Deal Summary 2012 61
Table 18: Novo Nordisk & University of Oxford, Deal Summary 2012 62
Table 19: Elan Corporation & University of Cambridge, Deal Summary 2012 63
Table 20: GSK & Yale University, Deal Summary 2012 64
Table 21: Pharma & Texas A&M University and Cornell Medical College, Deal Summary 2012 65
Table 22: Accuray & University of Heidelberg, Deal Summary 2012 66
Table 23: UCB & Oxford University, Deal Summary 2012 67
Table 24: Eli Lilly, Janssen, Pfizer, Roche & Kings College London, Deal Summary 2012 69
Table 25: Merck, Pharma & Biotech Start-ups, Deal Summary 2012 70
Table 26: Johnson & Johnson & University of Queensland, Deal Summary 2012 71
Table 27: Sanofi & University of California at San Francisco, Deal Summary 2012 73

List Of Figures

Figure 1: Lipitor Sales WW vs. US, 4Q11–4Q12 15
Figure 2: Pharmaceuticals and Healthcare, Number of Deals and Deal Values (US $m), Globally from September 2012 – February 2013 18
Figure 3: Pharmaceuticals & Healthcare, Number of Deals by Region, February 2013 19
Figure 4: Pharmaceuticals & Healthcare, Number of Deals by Therapy Area, February 2013 20
Figure 5: FDA Drug Approvals, 1995–2012 22
Figure 6: Academic Technology Transfer Deals and Deal Values (US $m), from 2007–2012 36

  • Overview of Global and Chinese 3D Printing Market 2015-2020
    ‘2015 3D Printing Industry Report -Global and Chinese Market’ is a comprehensive research report that describes the scope of the Global and Chinese 3D printing industry, analyzing the end-users behavior and the latest industry trends. Also, the report evaluates the growth prospects and the up-coming opportunities in the industry over the forecast period of 2015-2020. [...]
  • Schottky Diode Industry Research – 2015 Global and Chinese Market Overview
    ‘2015 Schottky Diode Industry Report – Global and Chinese Market Scenario’ is a top-notch research report, delivering premium industry insights and explanations of complex business scenarios. The report systematically articulates various growth prospects and current market challenges being faced by the existing industry players. The research report also drafts a meticulous business forecast that provides [...]
  • Codeine (CAS 76-57-3) Industry Research Report – 2009-2019 Market Forecast
    ‘Global and Chinese Codeine (CAS 76-57-3) Industry, 2009-2019 Market Research Report’, a systematically structured research report, that aims to deliver a detailed understanding of vivid market scenarios prevalent in the Codeine (CAS 76-57-3) industry to the user.  The report articulates various sections that thoroughly describe all key-aspects of the Codeine (CAS 76-57-3) industry. The report [...]
  • Global and Chinese Mainframe Banking Industry 2015 Outlook
    2015 Banks Mainframe Industry Report -Global and Chinese Market is a detailed market research report, delivering premium industry insights and analyzing the growth prospects of the industry over the forecast period of 2015-2020. The systematically structured sections of the research report, aims at conveying a strong business understanding to the user, enhancing the decision making [...]
  • Global and Chinese Market Situation of Milk Infant Formula Industry Over the Period of 2009-2019
    ‘Market Research Report on Global and Chinese Milk Infant Formula Industry, 2009-2019’ a comprehensive market study, that analyses various market landscape and key-aspects of the industry, delivering premium business insight and thorough understanding of the Global and Chinese market conditions to the user. Industry experts have methodologically structured the elaborative sections of the research report, [...]
    • The Oil Drilling Rig Industry
    • The Oil Drilling Rig Industry is characterized with a few typical work specific to this industry only. The work begins with the search for new oil basins or construction of wells. During this time the services of drilling contractors and se…

    • HER2-Negative Breast Cancer’s Therapeutic Market
    • HER2-Negative Breast Cancer is the most common form of cancer occurring in women. The long term survival of patients diagnosed with HER2-Negative Breast Cancer depends solely on its early detection as till now there is no medicine that can …

    • The Market of Plate Heat Exchanger
    • Plate heat exchanger is not only very useful but its also easy to maintain, its compact design makes it more efficient, the product is highly cost-efficient and also the materials of this product are easily available. There are some limitat…

    • The Industry of Binding Machines
    • Binding of books and papers is one of the most important aspect of buying and selling books and thus the demand of binding machines. There are different kinds of binding machines available in the market. The binding type determines the bind…

    • The Boom In Women Infertility Market
    • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Emerging Pharmaceutical Technologies - Stem cells
    Published: 15-Aug-2012        Price: US 3900 Onwards        Pages: 53
    Emerging Pharmaceutical Technologies - Stem cells Summary Stem cell technology is set to play a significant role in the pharmaceutical industry of the future. The opportunities for using stem cells across drug discovery, disease research, drug development and treatments are wide-ranging, yet largely unproven at present. Even if companies are not interested in joining the first wave of stem cell therapy developers, they need to be monitoring this sector ......
  • Global Pharmacy Automation Market 2012-2016
    Published: 22-Feb-2013        Price: US 2000 Onwards        Pages: 42
    TechNavio's analysts forecast the Global Pharmacy Automation Market to grow at a CAGR of 8.63 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in technological innovations. The Global Pharmacy Automation market has also been witnessing an increase in customer support services. However, the intense competition among vendors could pose a challenge to the growth of this market. TechNavio's report, the Global Pharmacy Automation Market 2......
  • Global MEMS Technology Market in the Healthcare Industry 2012-2016
    Published: 10-May-2013        Price: US 2000 Onwards        Pages: 37
    TechNavio's analysts forecast the Global MEM Technology market in the Healthcare industry to grow at a CAGR of 34.8 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for high operating speed medical devices. The Global MEM Technology market in the Healthcare industry has also been witnessing the miniaturization of medical electronic devices. However, the stringent regulatory rules which need to be followed during the development proc......
  • Global Biosimulation Market 2014-2018
    Published: 15-Nov-2013        Price: US 2500 Onwards        Pages: 62
    TechNavio's analysts forecast the Global Biosimulation market to grow at a CAGR of 18.31 percent over the period 2013-2018. One of the key factors contributing to this market growth is the reduction in drug discovery and development costs, owing to the deployment of biosimulation solutions. The Global Biosimulation market has also been witnessing increasing collaborations and partnerships. However, issues associated with the accuracy in prediction, could pose a challenge to the growth of this ma......
  • Global Robotic Surgery Market 2014-2018
    Published: 10-Jan-2014        Price: US 2000 Onwards        Pages: 49
    TechNavio's analysts forecast the Global Robotic Surgery market to grow at a CAGR of 11.65 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in the aging population. The Global Robotic Surgery market has also been witnessing the increase in automation. However, the high cost could pose a challenge to the growth of this market. TechNavio's report, the Global Robotic Surgery Market 2014-2018, has been prepared based on an in-depth marke......
  • Global Process Analytical Instrument Market 2014-2018
    Published: 28-Feb-2014        Price: US 2500 Onwards        Pages: 60
    TechNavio's analysts forecast the Global Process Analytical Instrumentation market to grow at a CAGR of 3.47 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to comply with stringent governmental regulations. The Global Process Analytical Instrumentation market has also been witnessing the emergence of technically advanced instruments. However, the need to offer customized instruments could pose a challenge to the growth of this market. ......
  • Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification, Sterilization, Virus Removal & Water Management), Region (North America, Europe, Asia-Pacific & ROW) - Trends & Forecast to 2018
    Published: 05-Mar-2014        Price: US 4650 Onwards        Pages: 195
    Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries. It finds extensive applications in the biopharmaceutical industry as biopharmaceutical products and their intermediates are susceptible to degradation due to heat and chemical treatment, and so are difficult to separate using other techniques. Membrane filtration has been used in pharmaceutical industry since 1935 and it is presently one of the most widely adopted separation techniques i......
  • Global Medical Technologies Market 2014-2018
    Published: 06-Aug-2014        Price: US 3000 Onwards        Pages: 122
    Medical technology is a collective term for software solutions, medical devices, imaging and diagnostic equipment used to ensure good health. The Global Medical Technologies market covers active implantable technology, hospital hardware, anaesthetic and respiratory technology, In vitro diagnostics technology, dental technology, electromechanical medical technology, technical aids for disabled, reusable instruments, non-active implantable technology, ophthalmic and optical technology, single-use ......
  • Medical Technology Market in Europe 2014-2018
    Published: 12-Nov-2014        Price: US 2500 Onwards        Pages: 99
    Medical technology refers to technology used in individuals suffering from wide range of conditions to ensure better health of the patients. It involves the entire pathway from diagnosis to cure of the patient. The medical technologies bring healthy life years, prevents disease progression, and show a vital role in healthcare. The Medical technology includes: software solutions, medical devices, imaging, biological derived devices, and diagnostic equipment; technologies such as active and non-ac......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs